Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients

BACKGROUND: Increasing evidence suggests that severe skeletal muscle index (SMI) loss (sarcopenia) is associated with poor overall survival in metastatic colorectal cancer patients, but its mechanisms are unknown. We recently found, using data of the randomized phase 3 CAIRO3 study, that SMI loss wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurk, Sophie, Peeters, Petra, Stellato, Rebecca, Dorresteijn, B., de Jong, Pim, Jourdan, Marion, Creemers, Geert‐Jan, Erdkamp, Frans, de Jongh, Felix, Kint, Peter, Simkens, Lieke, Tanis, Bea, Tjin‐A‐Ton, Manuel, Van Der Velden, Ankie, Punt, Cornelis, Koopman, Miriam, May, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711417/
https://www.ncbi.nlm.nih.gov/pubmed/31094083
http://dx.doi.org/10.1002/jcsm.12436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711417/
https://www.ncbi.nlm.nih.gov/pubmed/31094083
http://dx.doi.org/10.1002/jcsm.12436

Ejemplares similares